Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS FROM CONTINUING OPERATIONS

      Core Laboratories N.V. logo (PRNewsFoto/Core Laboratories N.V.)

      News provided by

      Core Laboratories N.V.

      Feb 01, 2023, 17:15 ET

      Share this article

      Share this article


      • FOURTH QUARTER REVENUE OF $128 MILLION; UP SLIGHTLY SEQUENTIALLY
      • FOURTH QUARTER OPERATING INCOME OF $16 MILLION; EX-ITEMS OF $15 MILLION, UP 10% SEQUENTIALLY
      • FOURTH QUARTER OPERATING MARGIN, EX-ITEMS, OF 12% WITH SEQUENTIAL INCREMENTAL MARGINS EXCEEDING 80%, DRIVEN BY PRODUCTION ENHANCEMENT
      • FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.20
      • FOURTH QUARTER CASH FROM OPERATIONS OF $13.2 MILLION
      • FOURTH QUARTER FREE CASH FLOW OF $11.2 MILLION
      • FOURTH QUARTER NET DEBT REDUCED BY $11.7 MILLION SEQUENTIALLY
      • COMPANY ANNOUNCED DELISTING FROM EURONEXT AND REDOMESTICATION TO THE U.S.
      • COMPANY ANNOUNCES Q1 2023 QUARTERLY DIVIDEND

      AMSTERDAM, Feb. 1, 2023 /PRNewswire/ -- Core Laboratories N.V. (NYSE: CLB) ("Core", "Core Lab", or the "Company") reported fourth quarter 2022 revenue of $127,600,000. Core's operating income was $15,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP").  The financial results for the fourth quarter of 2022 include a non-cash adjustment of $1,900,000, decreasing stock compensation expense associated with performance share awards that vested during the quarter.  Operating income, ex-items, a non-GAAP financial measure, was $14,700,000, yielding operating margins of 12%, and EPS, ex-items, of $0.20.  A full reconciliation of non-GAAP financial measures is included in the attached financial tables. 

      For 2022, Core's revenue of $489,700,000 increased 4% from the prior year.  Core's full-year revenue was adversely impacted by the devaluation of the Euro and British Pound when translated into U.S. dollars.  Using a constant U.S. dollar exchange rate, 2022 revenue would have been approximately $12,800,000 higher.  In addition, Core's 2022 revenue was also adversely impacted by the Russia-Ukraine conflict.  Across Core's European, Russian and Ukrainian operations, activity declined due to disruptions in crude-oil trading patterns, causing the Company's crude-oil assay and derived product testing revenue and product sales to decline in excess of $10,000,000 year-over-year.  The combined impact of these currency fluctuations and geopolitical factors adversely impacted 2022 revenue by approximately $22,800,000 year-over-year, substantially offsetting international growth in other regions.

      Core's CEO, Larry Bruno stated, "First, our thoughts remain with our Ukrainian employees and their families during the on-going conflict.  Despite the challenges posed by currency and geopolitical conflict, Core's results during the fourth quarter of 2022 displayed continued positive momentum, as we achieved sequential improvement in revenue, operating income, operating margins and EPS, with strong incremental margins. These improvements translated into higher free cash flow ("FCF"), which enabled the Company to decrease net debt by $11,700,000 or 7%, sequentially.  Core remains intently focused on executing against its key financial and operational strategies, including 1) reducing debt and strengthening our balance sheet, as well as 2) consistently pursuing efficiencies and the introduction of new technologies.  For 2023, Core sees the continuation of a multi-year recovery cycle for the oil and gas industry led by improvement in both onshore and offshore client activity across our global operations, although the Russia-Ukraine conflict continues to create volatility and uncertainties to growth prospects in Europe, Russia and Ukraine."

      Voluntary Delisting from Euronext and Redomestication to the United States

      On 4 November 2022, Core Lab announced its decision to voluntarily delist its shares from Euronext Amsterdam, and the last trading day for the Company's shares on the Euronext was 2 December 2022. The Company's shares continue to trade on the New York Stock Exchange under the symbol "CLB". 

      Following the delisting of the shares, on 17 January 2023, Core Lab announced plans to reorganize the Company's corporate structure, resulting in the redomestication of the parent company from the Netherlands to the United States (the "Redomestication").  The Company and its Board believes that the Redomestication will enhance shareholder value over the long-term through simplifying the corporate structure, improving operational efficiencies and reducing administrative costs.  The Redomestication, if approved by the Company's shareholders, will change the Company's jurisdiction of organization from the Netherlands to the State of Delaware.   

      Benefits of the Redomestication include: (i) a reduction in the corporate footprint and regulatory requirements associated with preparing duplicative audited financial statements and other reporting obligations, (ii) improved efficiencies and opportunities in the Company's corporate treasury, cash management, risk management and tax functions, and (iii) a simplified and more efficient tax structure.

      Reservoir Description

      Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S. Reservoir Description revenue in the fourth quarter of 2022 was $78,100,000, down slightly sequentially and year-over-year.  Geopolitical sanctions that became effective during the fourth quarter of 2022, further disrupted trading patterns of crude oil and derived products in Europe, Russia and Ukraine.  As a result, the demand for laboratory services in the fourth quarter of 2022 was adversely impacted, offsetting revenue growth in other international regions. Operating income for the fourth quarter of 2022 on a GAAP basis was $6,800,000, while operating income, ex-items, was $6,000,000, yielding operating margins of 8%.

      Reservoir Description revenue for 2022 was adversely impacted by the devaluation of the Euro and British Pound when translated into U.S. dollars.  Using a constant U.S. dollar exchange rate, Reservoir Description 2022 revenue would have been approximately $12,000,000 higher.  For 2022, revenue was also adversely impacted by the Russia-Ukraine conflict, declining over $9,000,000 compared to 2021.  Combined, these two factors adversely impacted Reservoir Description 2022 revenue by approximately $21,000,000, substantially offsetting international growth in other regions.

      During the fourth quarter of 2022, under the direction of a South American National Oil Company, Core Lab conducted a series of Enhanced Oil Recovery ("EOR") and flow assurance studies for a multi-well onshore program using CO2-rich injection gases.  The studies determined the impact of blending these CO2-rich gases with reservoir fluids and provided the basis for advanced equation-of-state modelling.  While defining the gas injection parameters for a successful field application are critical to improving crude oil recoveries, operators must simultaneously mitigate the flocculation of asphaltenes that result from CO2 injection, and which, can erase such gains.  CO2 injection projects reflect a globally expanding interest in EOR and Carbon Capture and Storage technologies.  When properly evaluated with rigorous laboratory testing, injecting CO2 into hydrocarbon-bearing subsurface formations can simultaneously improve oil recovery and reduce CO2 emissions.

      Also, during the fourth quarter of 2022, Core received both reservoir fluid and reservoir rock samples from Talos Energy Inc.'s Deepwater Gulf of Mexico Lime Rock and Venice prospects. Leveraging Core's experience with prior successful Gulf of Mexico drilling campaigns, the Company was able to quickly implement laboratory analytical protocols to fast-track results and evaluate reservoir potential within days of receiving the samples. The analytical results provided key reservoir parameters including: 1) an assessment of the pore system and fluid flow properties of these high-quality sandstone strata, 2) measurement of the crude oil and natural gas saturations in the recovered rocks, and 3) determination of key reservoir fluid properties such as the gas-oil ratio, and with the composition of the hydrocarbons.  Talos' experts incorporated these parameters into their assessment of the commercial viability of these prospects. Core's proprietary high pressure, high temperature, full visualization Pressure-Volume-Temperature technologies, along with the Company's extensive database of producing reservoirs in the Gulf of Mexico, helped Talos in this successful drilling program.

      Production Enhancement

      Production Enhancement operations, which are focused on complex completions in unconventional, tight-oil reservoirs in the U.S., as well as conventional projects across the globe, posted fourth quarter 2022 revenue of $49,400,000, increasing over 5% sequentially and 10% year-over-year.  Operating income on a GAAP basis was $7,900,000, while operating income, ex-items, was $7,700,000, yielding operating margins of 16% and sequential incremental margins, ex-items, in excess of 100%.  In addition, Core's proprietary diagnostic services grew over 22% sequentially and 17% year-over-year.

      During the fourth quarter of 2022, a U.S.-based operating company expressed the need to overcome injectivity challenges in their saltwater disposal wells.  Cost-effective disposal of produced frac fluid is critical to the financial success of unconventional resources.  Reservoir modeling determined that to optimize injection efficiencies, 14 zones dispersed across a 1,700 ft lateral wellbore needed to be perforated simultaneously in an over-balanced pressure configuration.  Core Lab provided a customized solution for this challenging technical problem by combining its proprietary Pulse Wave™ Tubular Conveyed System with its proprietary HERO® Hard Rock energetics.  Pulse Wave™ uses a unique energy transfer technology that can trigger multiple, unevenly-spaced perforating guns in a single downhole trip, eliminating the need for inert spacer guns between live guns to create a continuous communication string.  Eliminating the need for spacer guns reduces material cost and significantly reduces the rig time required to deploy the system. The HERO® Hard Rock energetic technology uses an advanced, patented, liner material technology that yields debris-free perforations, while also providing deep penetration and more effective flow efficiencies in hard rock formations.  By employing Pulse Wave™ technology, the client saved over 30% on the cost of consumables, in addition to reduced rig time.  The HERO® Hard Rock energetics created communication across each perforating interval, enabling the operator to establish the desired injection rate, which was double that of similar wells completed using conventional wireline perforating technologies.

      Liquidity, Free Cash Flow and Dividend

      Core continues to focus on maximizing FCF, a non-GAAP financial measure defined as cash from operations less capital expenditures.  For the fourth quarter of 2022, cash from operations was $13,200,000 and capital expenditures were $2,000,000, yielding FCF of $11,200,000.  Core's free cash will continue to be returned to its shareholders through the Company's regular quarterly dividend as well as being focused towards reducing long-term debt.

      During the fourth quarter of 2022, Core's net debt was reduced by $11,700,000, which also reduced the Company's leverage ratio to 2.29 as of 31 December 2022, down from 2.42 at the end of third quarter of 2022.  The Company will continue applying free cash towards reducing debt until the Company reaches its target leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) of 1.5 times or lower. 

      On 26 October 2022, Core's Board of Supervisory Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on 28 November 2022 to shareholders of record on 7 November 2022.  Dutch withholding tax was deducted from the dividend at a rate of 15%.

      On 1 February 2023, the Board approved a cash dividend of $0.01 per share of common stock payable on 6 March 2023 to shareholders of record on 13 February 2023.  Dutch withholding tax will be deducted from the dividend at a rate of 15%.

      Return On Invested Capital

      The Board and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return.  Core's commitment to an asset-light business model and disciplined capital stewardship promotes capital efficiency and is designed to produce more predictable and superior long-term ROIC.

      The Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total return to shareholders. Bloomberg's calculations using the latest comparable data available indicate Core Lab's ROIC improved to 7.2%.

      Industry and Core Lab Outlook and Guidance

      Looking forward into 2023, Core sees crude-oil macro fundamentals continuing to support a multi-year recovery cycle for the oil and gas industry.  Crude-oil demand for 2023, as forecast by the International Energy Agency in January 2023, is projected to increase by 1.9 million barrels per day ("mbpd") to a record 101.7 mbpd as consumption in China grows along with the reopening of its economy.  As crude-oil demand is projected to exceed pre-COVID levels, crude-oil supply is projected to tighten.  Production growth continues to face constraints due to prolonged underinvestment in many regions around the globe and the natural decline of production from existing fields.  As a result, Core Lab expects operators to expand their upstream spending plans for 2023 by mid-teens compared to 2022.  This supports Core's outlook for continued improvement in international onshore and offshore activity, with projects emerging and underway, most notably across the Middle East, Latin America and West Africa regions.

      Turning to the U.S., Core sees similar challenges with crude-oil supply which should require increased spending by operators to grow and replace production.  While operators remain focused on capital discipline, 2023 forecasts indicate their U.S. upstream spending will increase approximately 15% year-over-year.

      As customary, Core expects typical sequential seasonal industry patterns will cause activity in the first quarter of 2023 to decline in some regions.  As such, Core anticipates Reservoir Description first quarter 2023 revenue to be down low to mid-single digits, sequentially.  Continued volatility with crude-oil trading patterns may impact Core's Reservoir Description segment's international growth within its Russian, Ukrainian and European operations.  Production Enhancement segment revenue is estimated to be up mid-single digits as U.S. land activity is projected to recover from normal seasonal declines experienced at year-end.

      Core projects first quarter 2023 revenue to range from $125,000,000 to $129,000,000 and operating income of $11,500,000 to $14,500,000, yielding operating margins of approximately 10%.  EPS for the first quarter of 2023 is expected to be $0.14 to $0.19.

      The Company's first quarter 2023 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange.  First quarter 2023 guidance also assumes an effective tax rate of 20%.

      Earnings Call Scheduled

      The Company has scheduled a conference call to discuss Core's fourth quarter 2022 earnings announcement.  The call will begin at 7:30 a.m. CST / 2:30 p.m. CET on Thursday, 2 February 2023.  To listen to the call, please go to Core's website at www.corelab.com.

      Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the future revenue, profitability, business strategies and developments, including the Redomestication of the Company made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the ability to achieve the benefits of the Redomestication, international markets, international political climates, including the Russia-Ukraine geopolitical conflict, public health crises, such as the COVID-19 pandemic, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

      The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

      Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

      CORE LABORATORIES N.V. & SUBSIDIARIES
      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
      (In thousands, except per share data)
      (Unaudited)




      Quarter Ended



      % Variance




      December 31, 2022



      September 30, 2022



      December 31, 2021



      vs. Q3-2022


      vs. Q4-2021


      REVENUE


      $

      127,571



      $

      125,966



      $

      125,139



      1.3 %


      1.9 %

















      OPERATING EXPENSES:















      Costs of services and product sales



      99,816




      98,930




      96,987



      0.9 %


      2.9 %


      General and administrative expense



      8,724




      10,001




      10,927



      (12.8) %


      (20.2) %


      Depreciation and amortization



      4,073




      4,171




      4,398



      (2.3) %


      (7.4) %


      Other (income) expense, net



      (660)




      (1,781)




      (1,373)



      NM


      NM


      Total operating expenses



      111,953




      111,321




      110,939



      0.6 %


      0.9 %

















      OPERATING INCOME (LOSS)



      15,618




      14,645




      14,200



      6.6 %


      10.0 %


      Interest expense



      3,081




      3,138




      2,590



      (1.8) %


      19.0 %


      Income (loss) from continuing operations
         before income taxes



      12,537




      11,507




      11,610



      9.0 %


      8.0 %


      Income tax expense (benefit)



      5,847




      3,856




      8,823



      51.6 %


      (33.7) %


      Income (loss) from continuing operations



      6,690




      7,651




      2,787



      (12.6) %


      140.0 %


      Net income (loss)



      6,690




      7,651




      2,787



      (12.6) %


      140.0 %


      Net income (loss) attributable to non-
         controlling interest



      (61)




      127




      99



      NM


      NM


      Net income (loss) attributable to Core
         Laboratories N.V.


      $

      6,751



      $

      7,524



      $

      2,688



      (10.3) %


      151.2 %

















      Diluted earnings (loss) per share from
      continuing operations


      $

      0.14



      $

      0.16



      $

      0.06



      (12.5) %


      133.3 %

















      Diluted earnings (loss) per share
      attributable to Core Laboratories N.V.


      $

      0.14



      $

      0.16



      $

      0.06



      (12.5) %


      133.3 %

















      Diluted weighted average common shares
      outstanding



      46,826




      47,012




      46,927



      (0.4) %


      (0.2) %

















      Effective tax rate



      47

      %



      34

      %



      76

      %


      NM


      NM

















      SEGMENT INFORMATION:






























      Revenue:















      Reservoir Description


      $

      78,124



      $

      78,996



      $

      80,097



      (1.1) %


      (2.5) %


      Production Enhancement



      49,447




      46,970




      45,042



      5.3 %


      9.8 %


      Total


      $

      127,571



      $

      125,966



      $

      125,139



      1.3 %


      1.9 %

















      Operating income (loss):















      Reservoir Description


      $

      6,817



      $

      9,798



      $

      7,216



      (30.4) %


      (5.5) %


      Production Enhancement



      7,904




      4,417




      6,993



      78.9 %


      13.0 %


      Corporate and Other



      897




      430




      (9)



      NM


      NM


      Total


      $

      15,618



      $

      14,645



      $

      14,200



      6.6 %


      10.0 %

















      "NM" means not meaningful

















      CORE LABORATORIES N.V. & SUBSIDIARIES
      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
      (In thousands, except per share data)
      (Unaudited)




      Year Ended December 31,



      % Variance




      2022



      2021





      REVENUE


      $

      489,735



      $

      470,252



      4.1 %












      OPERATING EXPENSES:










      Costs of services and product sales



      393,655




      367,896



      7.0 %


      General and administrative expense



      38,117




      44,173



      (13.7) %


      Depreciation and amortization



      17,161




      18,516



      (7.3) %


      Other (income) expense, net



      (722)




      (5,595)



      NM


      Total operating expenses



      448,211




      424,990



      5.5 %












      OPERATING INCOME (LOSS)



      41,524




      45,262



      (8.3) %


      Interest expense



      11,570




      9,152



      26.4 %


      Income (loss) from continuing operations before income taxes



      29,954




      36,110



      (17.0) %


      Income tax expense (benefit)



      10,296




      15,891



      (35.2) %


      Income (loss) from continuing operations



      19,658




      20,219



      (2.8) %


      Net income (loss)



      19,658




      20,219



      (2.8) %


      Net income (loss) attributable to non-controlling interest



      205




      492



      NM


      Net income (loss) attributable to Core Laboratories N.V.


      $

      19,453



      $

      19,727



      (1.4) %












      Diluted earnings (loss) per share from continuing operations


      $

      0.42



      $

      0.43



      (2.3) %












      Diluted earnings (loss) per share attributable to Core Laboratories N.V.


      $

      0.42



      $

      0.42



      — %












      Diluted weighted average common shares outstanding



      46,813




      46,690



      0.3 %












      Effective tax rate



      34

      %



      44

      %


      NM












      SEGMENT INFORMATION:




















      Revenue:










      Reservoir Description


      $

      307,691



      $

      313,609



      (1.9) %


      Production Enhancement



      182,044




      156,643



      16.2 %


      Total


      $

      489,735



      $

      470,252



      4.1 %












      Operating income (loss):










      Reservoir Description


      $

      22,902



      $

      28,958



      (20.9) %


      Production Enhancement



      16,351




      15,163



      7.8 %


      Corporate and Other



      2,271




      1,141



      99.0 %


      Total


      $

      41,524



      $

      45,262



      (8.3) %












      "NM" means not meaningful










      CORE LABORATORIES N.V. & SUBSIDIARIES
      CONDENSED CONSOLIDATED BALANCE SHEETS
      (In thousands)
      (Unaudited) 













      % Variance


      ASSETS:


      December 31, 2022



      September 30, 2022



      December 31, 2021



      vs. Q3-2022


      vs. Q4-2021

















      Cash and cash equivalents


      $

      15,428



      $

      13,732



      $

      17,703



      12.4 %


      (12.9) %


      Accounts receivable, net



      106,913




      100,195




      96,830



      6.7 %


      10.4 %


      Inventories



      60,445




      54,795




      45,443



      10.3 %


      33.0 %


      Other current assets



      28,916




      26,493




      29,079



      9.1 %


      (0.6) %


      Total current assets



      211,702




      195,215




      189,055



      8.4 %


      12.0 %

















      Property, plant and equipment, net



      105,028




      107,252




      110,952



      (2.1) %


      (5.3) %


      Right of use assets



      52,379




      56,589




      61,387



      (7.4) %


      (14.7) %


      Intangibles, goodwill and other long-term assets, net



      209,245




      211,134




      219,459



      (0.9) %


      (4.7) %


      Total assets


      $

      578,354



      $

      570,190



      $

      580,853



      1.4 %


      (0.4) %

















      LIABILITIES AND EQUITY:






























      Accounts payable


      $

      45,847



      $

      34,343



      $

      29,726



      33.5 %


      54.2 %


      Operating lease liabilities



      11,699




      11,472




      12,342



      2.0 %


      (5.2) %


      Other current liabilities



      45,589




      41,544




      48,714



      9.7 %


      (6.4) %


      Total current liabilities



      103,135




      87,359




      90,782



      18.1 %


      13.6 %

















      Long-term debt, net



      172,386




      182,677




      188,636



      (5.6) %


      (8.6) %


      Long-term operating lease liabilities



      38,305




      41,975




      49,286



      (8.7) %


      (22.3) %


      Other long-term liabilities



      75,574




      74,886




      91,148



      0.9 %


      (17.1) %

















      Total equity



      188,954




      183,293




      161,001



      3.1 %


      17.4 %


      Total liabilities and equity


      $

      578,354



      $

      570,190



      $

      580,853



      1.4 %


      (0.4) %


      CORE LABORATORIES N.V. & SUBSIDIARIES
      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
      (In thousands)
      (Unaudited)




      Year Ended December 31,




      2022



      2021


      CASH FLOWS FROM OPERATING ACTIVITIES:







      Income (loss) from continuing operations


      $

      19,658



      $

      20,219


      Income (loss) from discontinued operations, net of income taxes



      —




      —


      Net income (loss)



      19,658




      20,219


      Adjustments to reconcile net income (loss) to net cash provided by operating activities:







      Stock-based compensation



      7,756




      19,093


      Depreciation and amortization



      17,161




      18,516


      Deferred income taxes



      433




      6,012


      Gain on sale of business



      —




      (1,012)


      Accounts receivable



      (10,078)




      (13,522)


      Inventories



      (14,860)




      (4,547)


      Accounts payable



      15,374




      6,568


      Other adjustments to net income (loss)



      (10,488)




      (14,748)


      Net cash provided by operating activities



      24,956




      36,579









      CASH FLOWS FROM INVESTING ACTIVITIES:







      Capital expenditures



      (10,216)




      (13,539)


      Proceeds from insurance recovery



      583




      726


      Other investing activities



      5,777




      2,590


      Net cash used in investing activities



      (3,856)




      (10,223)









      CASH FLOWS FROM FINANCING ACTIVITIES:







      Repayment of long-term debt



      (131,000)




      (226,000)


      Proceeds from long-term debt



      116,000




      155,000


      Proceeds from issuance of common shares



      —




      60,000


      Transaction costs on equity distribution program



      (411)




      (861)


      Dividends paid



      (1,853)




      (1,834)


      Repurchase of common shares



      (3,903)




      (8,256)


      Other financing activities



      (2,208)




      (508)


      Net cash used in financing activities



      (23,375)




      (22,459)









      NET CHANGE IN CASH AND CASH EQUIVALENTS



      (2,275)




      3,897


      CASH AND CASH EQUIVALENTS, beginning of year



      17,703




      13,806


      CASH AND CASH EQUIVALENTS, end of year


      $

      15,428



      $

      17,703


      Non-GAAP Information

      Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

      Reconciliation of Operating Income (Loss), Income (Loss) from Continuing Operations and
      Diluted Earnings (Loss) Per Share from Continuing Operations
      (In thousands, except per share data)
      (Unaudited)




      Operating Income (Loss)




      Quarter Ended




      December 31, 2022



      September 30, 2022



      December 31, 2021


      GAAP reported


      $

      15,618



      $

      14,645



      $

      14,200


      Stock compensation (1)



      (1,868)




      —




      —


      Redomestication costs



      246




      —




      —


      Foreign exchange losses (gains)



      691




      (1,303)




      (32)


      Excluding specific items


      $

      14,687



      $

      13,342



      $

      14,168





      Income (Loss) from Continuing Operations




      Quarter Ended




      December 31, 2022



      September 30, 2022



      December 31, 2021


      GAAP reported


      $

      6,690



      $

      7,651



      $

      2,787


      Stock compensation (1)



      (1,494)




      —




      —


      Redomestication costs



      197




      —




      —


      Foreign exchange losses (gains)



      552




      (1,043)




      (26)


      Debt issuance costs write off  (3)



      —




      171




      —


      Impact of higher (lower) tax rate (4)



      3,341




      1,553




      6,501


      Excluding specific items


      $

      9,286



      $

      8,332



      $

      9,262





      Diluted Earnings (Loss) Per Share from Continuing Operations




      Quarter Ended



      Year ended




      December 31, 2022



      September 30, 2022



      December 31, 2021



      December 31, 2022


      GAAP reported


      $

      0.14



      $

      0.16



      $

      0.06



      $

      0.42


      Stock compensation (1), (2)



      (0.03)




      —




      —




      (0.01)


      Severance and other charges



      —




      —




      —




      0.06


      Bad debt



      —




      —




      —




      0.01


      Foreign exchange losses (gains)



      0.02




      (0.01)




      —




      0.01


      Impact of higher (lower) tax rate (4)



      0.07




      0.03




      0.14




      0.08


      Excluding specific items


      $

      0.20



      $

      0.18



      $

      0.20



      $

      0.57















      (1) Quarter ended December 31, 2022 includes non-cash adjustment of stock compensation expense associated with certain performance
            share awards that vested during the quarter.


      (2) The year ended December 31, 2022 includes non-cash adjustment of stock compensation expense for shares that were granted but did
            not vest. The period also includes stock compensation expense recognized pursuant to FASB ASC 718 "Stock Compensation"
            associated with employees reaching eligible retirement age, which is nondeductible or partially deductible for tax purposes.


      (3) Quarter ended September 30, 2022 includes debt issuance costs written off upon renewal of the credit facility.


      (4) Includes adjustments to reflect tax expense at a normalized rate of 20%.


      Segment Information
      (In thousands)
      (Unaudited)




      Operating Income (Loss) from Continuing Operations




      Quarter Ended December 31, 2022




      Reservoir Description



      Production Enhancement



      Corporate and Other


      GAAP reported


      $

      6,817



      $

      7,904



      $

      897


      Stock compensation (1)



      (1,250)




      (618)




      —


      Redomestication costs



      156




      90




      —


      Foreign exchange losses (gains)



      321




      309




      61


      Excluding specific items


      $

      6,044



      $

      7,685



      $

      958












      (1) Quarter ended December 31, 2022 includes non-cash adjustment of stock compensation expense associated with certain performance
            share awards that vested during the quarter.


      Return on Invested Capital

      Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

      ROIC of 7.2% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $26.8 million divided by Average Total Invested Capital ("Average TIC") of $372.9 million where NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and tax effect on income before interest and tax expense. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes, and income taxes payable.

      Free Cash Flow

      Core uses the non-GAAP measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative consideration to operating income, net income, earnings per share, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

      Computation of Free Cash Flow
      (In thousands)
      (Unaudited)




      Quarter Ended



      Year Ended




      December 31, 2022



      December 31, 2022


      Net cash provided by operating activities


      $

      13,211



      $

      24,956


      Capital expenditures



      (2,021)




      (10,216)


      Free cash flow


      $

      11,190



      $

      14,740


      SOURCE Core Laboratories N.V.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.